Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109

NCT01640912 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Cicatrix
Scar Prevention

Interventions

DRUG: RXI-109
DRUG: Placebo

Sponsor

RXi Pharmaceuticals, Corp.